Biosimilars pipeline report: A guide for understanding the growing market
By Amerisourcebergen
To date, there have been 40 approvals and 29 launches in the U.S. biosimilars market
Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. As this market matures, its pipeline continues to grow. This reference guide is a useful tool to visualize and understand the current product landscape and potential future of this emerging market.
Learn more about our biosimilar solutions
At AmerisourceBergen, we believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.
Topics:
Biosimilars
Our role in healthcare
